We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Vaccines company China NT Pharma closes HKD1.07bn IPO on HKSE
18 Aug 2011
Executive Summary
China NT Pharma Group Co. Ltd. (vaccines distributor) has netted HKD1.07bn ($137.6mm). in a global initial public offering of 270.5mm new shares at HKD$4.54, the low end of its anticipated HKD4.54-6.00 range. Included in the offering are 35.7mm Hong Kong shares and 234.8mm International Placing shares.
Deal Industry
Distributors
Pharmaceuticals
Services
Pharmaceuticals
Vaccines
Deal Status
Final
Deal Type
Financing
IPO
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?